|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910819676503321 |
|
|
Titolo |
Countering the problem of falsified and substandard drugs / / Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, District of Columbia : , : National Academies Press, , [2013] |
|
©2013 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (375 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Pharmaceutical industry - Quality control |
Fraud - Prevention |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Nota di contenuto |
|
""Front Matter""; ""Reviewers""; ""Acknowledgments""; ""Acronyms and Abbreviations""; ""Contents""; ""Boxes, Figures, and Tables""; ""Summary""; ""1 Introduction""; ""2 The Effects of Falsified and Substandard Drugs""; ""3 The Magnitude of the Problem""; ""4 Causes of Falsified and Substandard Drugs""; ""5 Weaknesses in the Drug Distribution Chain""; ""6 Detection Technology""; ""7 An International Code of Practice for Falsified and Substandard Medicines""; ""Appendix A: Glossary""; ""Appendix B: Committee Biographies""; ""Appendix C: Meeting Agendas"" |
|
|
|
|
|
|
|